Yahoo Web Search

Search results

    • Telix Pharmaceuticals (OTCMKTS:TLPPF) Shares Up 0.8%

      ETF DAILY NEWS· 6 days ago

      Its lead products include TLX591-CDx for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX250-CDx that is in Phase III clinical trials for the treatment and diagnosis ...